Cargando…
Superwellness Program: a cognitive-behavioral therapy-based group intervention to reduce weight gain in patients treated with antipsychotic drugs
OBJECTIVE: To assess the effectiveness of a cognitive-behavioral therapy-based intervention (Superwellness Program) on weight gain compared with a treatment-as-usual (TAU) approach in patients treated with antipsychotics, and to evaluate the relationship between body mass index (BMI) variation and c...
Autores principales: | Magni, Laura R., Ferrari, Clarissa, Rossi, Giuseppe, Staffieri, Elena, Uberti, Aldo, Lamonaca, Dario, Boggian, Ileana, Merlin, Silvia, Primerano, Giuseppe, Mombrini, Alessandra, Poli, Roberto, Saviotti, Francesco M., Caldera, Maria T., Zanotti, Luciana, Rossi, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111394/ https://www.ncbi.nlm.nih.gov/pubmed/28300948 http://dx.doi.org/10.1590/1516-4446-2016-1993 |
Ejemplares similares
-
“The Italian Study on Recovery 2” Phase 1: Psychometric Properties of the Recovery Assessment Scale (RAS), Italian Validation of the Recovery Assessment Scale
por: Boggian, Ileana, et al.
Publicado: (2020) -
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
por: Pietrini, Francesco, et al.
Publicado: (2019) -
S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020) -
Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations
por: Rossi, Giuseppe, et al.
Publicado: (2012) -
Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia
por: Kakunje, Anil, et al.
Publicado: (2018)